Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in MBIO — Mustang Bio, Inc.

CIK 1214717 BOSTON, MA
Back to MBIO Full portfolio

Position in MBIO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$29,651
-$37,899 QoQ
Shares Held
42,240
-54.5% QoQ
Ownership
0.557%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 23 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,296,497 across 521 Biotechnology names. MBIO ranks #492 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in MBIO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $29,651 42,240
2026-03-31 $67,550 92,790
2025-12-31 $31,671 32,285
2025-09-30 $40,154 26,418
2025-06-30 $15,358 16,082
2025-03-31 $19,708 15,767
2024-12-31 $50,345 284,437
2024-09-30 $57,688 245,486
2024-06-30 $35,366 74,772
2024-03-31 $50,332 48,397
2023-12-31 $67,224 49,796
2023-09-30 $103,077 49,796
2023-06-30 $309,022 49,762
2023-03-31 $226,653 617,584
2022-12-31 $243,945 617,584
2022-09-30 $290,333 619,047
2022-06-30 $362,142 619,047
2022-03-31 $1,268,810 1,256,248
2021-12-31 $2,168,212 1,306,152
2021-09-30 $3,621,078 1,346,126
2021-06-30 $4,014,806 1,209,279
2021-03-31 $2,959,736 891,487
2020-12-31 $2,959,994 782,033
2020-09-30 $1,667,827 529,469
2020-06-30 $1,373,899 432,044
2020-03-31 $1,088,374 406,110